NCT07725146 Turkish Validation of the Rapprich Lipedema Symptomatic Assessment Questionnaire
| NCT ID | NCT07725146 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Marmara University |
| Condition | Lipedema |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2026-07-17 |
| Primary Completion | 2027-02-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2026-07-17 with a primary completion date of 2027-02-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lipedema is a chronic disease characterized by abnormal fat accumulation, primarily in the lower extremities, affecting women. This study aims to evaluate the validity and reliability of the Turkish version of the Rapprich Lipedema Symptomatic Assessment Questionnaire, which was originally developed by Rapprich et al. in 2010. Since a validated Turkish version is currently unavailable, this research will provide a standardized tool for clinicians to assess symptomatic severity in Turkish-speaking lipedema patients.
Eligibility Criteria
Inclusion Criteria: * Female patients aged 18-75. * Diagnosed with lipedema by a clinician. * Willingness to participate and sign the informed consent form. Exclusion Criteria: * Positive Stemmer sign or presence of advanced-stage lymphedema. * Diagnosis of Heart Failure. * Chronic Kidney Disease. * Pregnancy. * BMI \> 50 kg/m².
Contact & Investigator
Canan Şanal, Assoc. Prof.
PRINCIPAL INVESTIGATOR
Marmara University Faculty of Medicine
Frequently Asked Questions
Who can join the NCT07725146 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 75 Years, studying Lipedema. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07725146 currently recruiting?
Yes, NCT07725146 is actively recruiting participants. Contact the research team at canansanal@hotmail.com for enrollment information.
Where is the NCT07725146 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye), Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07725146 clinical trial?
NCT07725146 is sponsored by Marmara University. The principal investigator is Canan Şanal, Assoc. Prof. at Marmara University Faculty of Medicine. The trial plans to enroll 180 participants.